SCHEMBL249302

SCHEMBL249302

CCCCc1nc2c(F)cccc2cc1CCNc1ncnc2[nH]cnc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 3/20 0.41
LMNA P02545 7/20 0.39
HTT P42858 5/20 0.39
MAPK1 P28482 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
PDE4A P27815 1/20 0.38
PDE4B Q07343 1/20 0.38
PDE4C Q08493 1/20 0.38
PDE4D Q08499 1/20 0.38
TLR8 Q9NR97 1/20 0.35
TLR7 Q9NYK1 1/20 0.35
MAPT P10636 4/20 0.34
GFER P55789 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
HSD17B10 Q99714 3/20 0.34
ALOX15 P16050 2/20 0.34
TSHR P16473 2/20 0.34
TP53 P04637 2/20 0.34
NPSR1 Q6W5P4 1/20 0.34
TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL249677 0.83 PIK3CD (0.36) PIK3CDLMNAHTTMAPK1SMN1; SMN2
SCHEMBL3414418 0.81 PIK3CD (0.39) PIK3CDRPS6KB1MAP4K4EGFR
SCHEMBL249301 0.81 PIK3CD (0.39) PIK3CDRPS6KB1MAP4K4EGFR
SCHEMBL4434824 0.81 LMNA (0.42) PIK3CDLMNAHTTMAPK1SMN1; SMN2
SCHEMBL250361 0.80 PIK3CD (0.38) PIK3CDLMNAHTTMAPK1SMN1; SMN2
SCHEMBL16799113 0.80 LMNA (0.39) PIK3CDLMNAHTTMAPK1SMN1; SMN2
SCHEMBL249910 0.80 PIK3CD (0.37) PIK3CDLMNAHTTMAPK1SMN1; SMN2
SCHEMBL4433351 0.79 MAP4K4 (0.41) PIK3CDLMNAHTTMAPK1SMN1; SMN2
SCHEMBL4563263 0.79 PIK3CD (0.40) PIK3CDLMNASMN1; SMN2HSD17B10EGFR
SCHEMBL4563262 0.79 PIK3CD (0.40) PIK3CDLMNASMN1; SMN2HSD17B10EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2588469-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE AS INHIBITORS OF PI3K ACTIVITY Amgen Inc. (US) 2013-05-08 EP disclosed
WO-2012003271-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE AS INHIBITORS OF PI3K ACTIVITY AMGEN INC. (US) 2012-01-05 WO disclosed